Antimicrobial resistance (AMR) poses a profound threat to human health, undermining the efficacy of antibiotics that have been the cornerstone of modern medicine.
As bacteria, viruses, fungi, and parasites evolve to resist the effects of medications, common infections become harder to treat, leading to longer illnesses, higher medical costs, and increased mortality.
Articles
Explainer: Antimicrobial resistance (AMR)
AMR occurs when microbes, such as bacteria, viruses, fungi, and parasites evolve to resist the drugs designed to kill them, rendering treatments ineffective.
How vaccines can help mitigate AMR
Next-gen vaccines targeting bacterial infections will take the pressure off antibiotics.
AI a potential game-changer for antibiotic drug development
AI Machine Learning could potentially unblock the antimicrobial drug development pipeline.
Six strategies to minimise AMR in Australia
Six key ways that Australia can shore up its antimicrobial stewardship, including optimising antimicrobial use and increasing education.
Patients have a common enemy in AMR
The rise of antimicrobial resistance (AMR) is a growing concern for patients who are immunosuppressed and predisposed to infections.
Developing new antibiotics: why Netflix-like incentives could be key
The push and pull ideas helping to bring new antibiotics to market.
Alarming rates of AMR in remote Indigenous communities
Why housing is key to managing AMR for First Nations people.
Why don’t we know the exact death toll of AMR in Australia?
Knowing the exact death toll of AMR is tricky but essential.
Better diagnostics can combat the rise of antimicrobial resistance
The right tools at the right time can make all the difference.
Securing antibiotic supply chains by working together
Pooling resources with regional neighbours could help manage supply of essential medicines.
The economic cost of AMR in healthcare
AMR is putting our healthcare system under huge financial strain.
